Home
PPBT
PPBT News

Latest Purple Biotech Ltd. (PPBT) News on June 29, 2025

Purple Biotech Highlights Significant Advantages of the Novel CAPTN-3 Tri-Specific Antibody Platform at the EACR 2025 Annual Congress

GlobeNewswire

6 days ago

Purple Biotech Highlights Significant Advantages of the Novel CAPTN-3 Tri-Specific Antibody Platform at the EACR 2025 Annual Congress

Purple Biotech Announces Initiation of Phase 2 Study of NT219 in Patients with Head and Neck Cancer

GlobeNewswire

12 days ago

Purple Biotech Announces Initiation of Phase 2 Study of NT219 in Patients with Head and Neck Cancer

Purple Biotech Announces Poster Presentation at EACR 2025 on its Novel CAPTN-3 Tri-Specific Antibody Platform

GlobeNewswire

25 days ago

Purple Biotech Announces Poster Presentation at EACR 2025 on its Novel CAPTN-3 Tri-Specific Antibody Platform

Purple Biotech Reports First Quarter 2025 Financial Results

GlobeNewswire

a month ago

Purple Biotech Reports First Quarter 2025 Financial Results

Purple Biotech Appoints Shai Lankry as Chief Financial Officer

GlobeNewswire

2 months ago

Purple Biotech Appoints Shai Lankry as Chief Financial Officer

Purple Biotech Reports Final Data from Phase 2 Study of CM24 in Pancreatic Cancer Patients at AACR 2025 Annual Meeting: Improved Outcomes and Significant Efficacy in Biomarker-Enriched Subgroups

GlobeNewswire

2 months ago

Purple Biotech Reports Final Data from Phase 2 Study of CM24 in Pancreatic Cancer Patients at AACR 2025 Annual Meeting: Improved Outcomes and Significant Efficacy in Biomarker-Enriched Subgroups

Purple Biotech Reports Positive NT219 Data at AACR for Colorectal and Head and Neck Cancers

GlobeNewswire

2 months ago

Purple Biotech Reports Positive NT219 Data at AACR for Colorectal and Head and Neck Cancers

Purple Biotech Announces Publication in the Neuro Oncology Journal Demonstrating the Potential of NT219 to Suppress Brain Metastasis of Colorectal Cancer

GlobeNewswire

2 months ago

Purple Biotech Announces Publication in the Neuro Oncology Journal Demonstrating the Potential of NT219 to Suppress Brain Metastasis of Colorectal Cancer

Purple Biotech to Participate in Panel Discussion at Canaccord Genuity Horizons in Oncology Virtual Conference on April 7, 2025

GlobeNewswire

3 months ago

Purple Biotech to Participate in Panel Discussion at Canaccord Genuity Horizons in Oncology Virtual Conference on April 7, 2025

Purple Biotech Announces Three Posters Accepted for Presentation at the 2025 American Association for Cancer Research Meeting

GlobeNewswire

3 months ago

Purple Biotech Announces Three Posters Accepted for Presentation at the 2025 American Association for Cancer Research Meeting

Purple Biotech Reports Fourth Quarter and Full-Year 2024 Financial Results

GlobeNewswire

4 months ago

Purple Biotech Reports Fourth Quarter and Full-Year 2024 Financial Results

Purple Biotech Granted New U.S. Patent for NT219 in Combination with EGFR Antibody Therapy, Enhancing Global IP Protection in Major Markets

GlobeNewswire

4 months ago

Purple Biotech Granted New U.S. Patent for NT219 in Combination with EGFR Antibody Therapy, Enhancing Global IP Protection in Major Markets

Purple Biotech Advances NT219 into Phase 2 Head and Neck Cancer Trial

GlobeNewswire

4 months ago

Purple Biotech Advances NT219 into Phase 2 Head and Neck Cancer Trial

Purple Biotech Announces Research Collaboration with the Icahn School of Medicine at Mount Sinai for CAPTN-3 Tri-Specific Antibody Platform

GlobeNewswire

5 months ago

Purple Biotech Announces Research Collaboration with the Icahn School of Medicine at Mount Sinai for CAPTN-3 Tri-Specific Antibody Platform

Purple Biotech Announces Closing of $2.8 Million Registered Direct Offering of American Depositary Shares

GlobeNewswire

7 months ago

Purple Biotech Announces Closing of $2.8 Million Registered Direct Offering of American Depositary Shares

Purple Biotech Announces $2.8 Million Registered Direct Offering of American Depositary Shares

GlobeNewswire

7 months ago

Purple Biotech Announces $2.8 Million Registered Direct Offering of American Depositary Shares

Purple Biotech Reports Positive Final Results from Randomized Phase 2 Study of CM24 in Second Line Pancreatic Cancer

GlobeNewswire

7 months ago

Purple Biotech Reports Positive Final Results from Randomized Phase 2 Study of CM24 in Second Line Pancreatic Cancer

Purple Biotech Reports Third Quarter 2024 Financial Results

GlobeNewswire

7 months ago

Purple Biotech Reports Third Quarter 2024 Financial Results

Purple Biotech Unveils Promising Biomarker for Cancer Therapy

TipRanks

8 months ago

Purple Biotech Unveils Promising Biomarker for Cancer Therapy

Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24: Associated with 79% Reduction in Risk of Death

GlobeNewswire

8 months ago

Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24: Associated with 79% Reduction in Risk of Death

Purple Biotech Presents New Data for its Novel Tri-Specific T Cell and NK Cell Engagers Antibody Platform, CAPTN-3, at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

GlobeNewswire

8 months ago

Purple Biotech Presents New Data for its Novel Tri-Specific T Cell and NK Cell Engagers Antibody Platform, CAPTN-3, at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Purple Biotech Unveils CAPTN-3 Cancer Therapy

TipRanks

9 months ago

Purple Biotech Unveils CAPTN-3 Cancer Therapy

Purple Biotech to Present Data for its Tri-Specific Antibody Platform—CAPTN-3—at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

GlobeNewswire

9 months ago

Purple Biotech to Present Data for its Tri-Specific Antibody Platform—CAPTN-3—at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Purple Biotech Reports Additional Positive Interim Data from its Randomized Phase 2 Study with its Lead Oncology Therapeutic Candidate CM24

GlobeNewswire

9 months ago

Purple Biotech Reports Additional Positive Interim Data from its Randomized Phase 2 Study with its Lead Oncology Therapeutic Candidate CM24

Upcoming Stock Splits This Week (September 16 to September 20) – Stay Invested

TipRanks

9 months ago

Upcoming Stock Splits This Week (September 16 to September 20) – Stay Invested

Purple Biotech to Present Data for its Lead Oncology Drug CM24 at the AACR Special Conference on Advances in Pancreatic Cancer Research

GlobeNewswire

10 months ago

Purple Biotech to Present Data for its Lead Oncology Drug CM24 at the AACR Special Conference on Advances in Pancreatic Cancer Research

Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

10 months ago

Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment Conference

Purple Biotech Reports Second Quarter 2024 Financial Results and Business Highlights

GlobeNewswire

10 months ago

Purple Biotech Reports Second Quarter 2024 Financial Results and Business Highlights

Purple Biotech Receives Extension to Regain Compliance with the Nasdaq’s Minimum Bid Price Rule

GlobeNewswire

a year ago

Purple Biotech Receives Extension to Regain Compliance with the Nasdaq’s Minimum Bid Price Rule

Purple Biotech to Host Virtual KOL Event to Discuss Positive Interim Results from Phase 2 Pancreatic Cancer Study with CM24 on July 11, 2024

GlobeNewswire

a year ago

Purple Biotech to Host Virtual KOL Event to Discuss Positive Interim Results from Phase 2 Pancreatic Cancer Study with CM24 on July 11, 2024

Purple Biotech Announces Closing of Exercise of Warrants for $2 Million Gross Proceeds

GlobeNewswire

a year ago

Purple Biotech Announces Closing of Exercise of Warrants for $2 Million Gross Proceeds

Purple Biotech Announces Exercise of Warrants for $2 Million Gross Proceeds

GlobeNewswire

a year ago

Purple Biotech Announces Exercise of Warrants for $2 Million Gross Proceeds

Purple Biotech Reports Additional Positive Interim Results from its Randomized Phase 2 Pancreatic Cancer Study with CM24 Regarding a Potential Predictive Biomarker for Overall Survival Benefit

GlobeNewswire

a year ago

Purple Biotech Reports Additional Positive Interim Results from its Randomized Phase 2 Pancreatic Cancer Study with CM24 Regarding a Potential Predictive Biomarker for Overall Survival Benefit

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

Yahoo Finance Video

a year ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

GlobeNewswire

a year ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit

Reuters

a year ago

California seeks company profits in Big Oil climate lawsuit

USA TODAY

a year ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

GlobeNewswire

a year ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Business Wire

a year ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

GlobeNewswire

a year ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Business Wire

a year ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and other Efficacy Endpoints in Pancreatic Cancer

GlobeNewswire

a year ago

Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and other Efficacy Endpoints in Pancreatic Cancer

Purple Biotech Reports First Quarter 2024 Financial Results

GlobeNewswire

a year ago

Purple Biotech Reports First Quarter 2024 Financial Results

Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting

GlobeNewswire

a year ago

Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting

Purple Biotech to Present New Data On its Oncology Drug NT219 at AACR 2024

GlobeNewswire

a year ago

Purple Biotech to Present New Data On its Oncology Drug NT219 at AACR 2024

Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform Technology

GlobeNewswire

a year ago

Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform Technology

Purple Biotech Reports Fourth Quarter and Full-Year 2023 Financial Results

GlobeNewswire

a year ago

Purple Biotech Reports Fourth Quarter and Full-Year 2023 Financial Results

Purple Biotech Presents Data of its Phase 1 Head & Neck Cancer of NT219 in combination with Cetuximab at ESMO TAT Congress 2024

GlobeNewswire

a year ago

Purple Biotech Presents Data of its Phase 1 Head & Neck Cancer of NT219 in combination with Cetuximab at ESMO TAT Congress 2024

Purple Biotech Convenes a Head & Neck Cancer Scientific Advisory Board in Preparation for NT219 Phase 2 Trial

GlobeNewswire

a year ago

Purple Biotech Convenes a Head & Neck Cancer Scientific Advisory Board in Preparation for NT219 Phase 2 Trial

GlobeNewswire

a year ago

Purple Biotech Reaches Recommended Phase 2 Dose for NT219

Zacks Small Cap Research

a year ago

KA: Phase I/II Update

Should Value Investors Buy EuroDry (EDRY) Stock?

Zacks

a year ago

Should Value Investors Buy EuroDry (EDRY) Stock?

Investing in Pyxis Tankers (NASDAQ:PXS) five years ago would have delivered you a 16% gain

Simply Wall St.

a year ago

Investing in Pyxis Tankers (NASDAQ:PXS) five years ago would have delivered you a 16% gain

Dolphin Entertainment Congratulates 42West and its Clients for Securing 24 Nominations for the 96th Academy Awards

ACCESSWIRE

a year ago

Dolphin Entertainment Congratulates 42West and its Clients for Securing 24 Nominations for the 96th Academy Awards

Canoo Reaches Agreement with U.S. Postal Service for Purchase of Electric Vehicles

GlobeNewswire

a year ago

Canoo Reaches Agreement with U.S. Postal Service for Purchase of Electric Vehicles

Via Renewables, Inc. Announces Dividend on Preferred Stock

ACCESSWIRE

a year ago

Via Renewables, Inc. Announces Dividend on Preferred Stock

Kineta Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors

GlobeNewswire

a year ago

Kineta Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors

How Beamr Technology Can Boost Machine Learning

ACCESSWIRE

a year ago

How Beamr Technology Can Boost Machine Learning

Arqit announces reseller agreement with Phalanx

GlobeNewswire

a year ago

Arqit announces reseller agreement with Phalanx

Sadot Group Inc. Announces New Trading Arm - Sadot Brasil Ltda

ACCESSWIRE

a year ago

Sadot Group Inc. Announces New Trading Arm - Sadot Brasil Ltda

BurgerFi Provides Fiscal Year 2023 Business Update

GlobeNewswire

a year ago

BurgerFi Provides Fiscal Year 2023 Business Update

Kineta to Participate in the 13th Annual LifeSci Partners Corporate Access Event

GlobeNewswire

a year ago

Kineta to Participate in the 13th Annual LifeSci Partners Corporate Access Event

BurgerFi to Participate in the 26th Annual ICR Conference

GlobeNewswire

a year ago

BurgerFi to Participate in the 26th Annual ICR Conference

CMCT Declares Preferred Stock Dividends

Business Wire

a year ago

CMCT Declares Preferred Stock Dividends

Business Wire

a year ago

SIFCO Industries, Inc. ("SIFCO") Announces Fourth Quarter and Full Year Fiscal 2023 Financial Results

NLS Pharmaceutics CEO Issues Letter to Shareholders

ACCESSWIRE

a year ago

NLS Pharmaceutics CEO Issues Letter to Shareholders

Reuters

2 years ago

AlloVir scraps late-stage studies testing antiviral cell therapy

AlloVir Provides Updates on Phase 3 Clinical Development Program for Posoleucel, an Allogeneic Virus-Specific T Cell Therapy

GlobeNewswire

2 years ago

AlloVir Provides Updates on Phase 3 Clinical Development Program for Posoleucel, an Allogeneic Virus-Specific T Cell Therapy

NextCure Publishes Non-Clinical Data Demonstrating Anti-Siglec-15 Treatment Prevented Bone Loss Due to Immobilization from Acute Spinal Cord Injury

GlobeNewswire

2 years ago

NextCure Publishes Non-Clinical Data Demonstrating Anti-Siglec-15 Treatment Prevented Bone Loss Due to Immobilization from Acute Spinal Cord Injury

Purple Biotech Appoints Dr. Yael Margolin to its Board of Directors

GlobeNewswire

2 years ago

Purple Biotech Appoints Dr. Yael Margolin to its Board of Directors

Life Science Investor Forum: Presentations Now Available for Online Viewing

GlobeNewswire

2 years ago

Life Science Investor Forum: Presentations Now Available for Online Viewing

Integra Publishes Annual Sustainability Report and Provides Stakeholder Update

GlobeNewswire

2 years ago

Integra Publishes Annual Sustainability Report and Provides Stakeholder Update

Aspira Women’s Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024

GlobeNewswire

2 years ago

Aspira Women’s Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024

Purple Biotech Completes Patient Enrollment in Phase 2 Pancreatic Cancer Trial

GlobeNewswire

2 years ago

Purple Biotech Completes Patient Enrollment in Phase 2 Pancreatic Cancer Trial

The 3 Most Undervalued AI Penny Stocks to Buy in December

InvestorPlace

2 years ago

The 3 Most Undervalued AI Penny Stocks to Buy in December

New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10:30 PM PT

GlobeNewswire

2 years ago

New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10:30 PM PT

G1 Therapeutics Presents New Post Hoc Analyses Indicating That Patients Who Previously Received Trilaciclib Have Improved Overall Survival with Subsequent Anticancer Therapy

GlobeNewswire

2 years ago

G1 Therapeutics Presents New Post Hoc Analyses Indicating That Patients Who Previously Received Trilaciclib Have Improved Overall Survival with Subsequent Anticancer Therapy

Penny Stock Jackpots: 3 High-Stakes Picks With 10-Bagger Potential

InvestorPlace

2 years ago

Penny Stock Jackpots: 3 High-Stakes Picks With 10-Bagger Potential

Annovis Bio (ANVS) Stock Surges 38% in a Month: Here's Why

Zacks

2 years ago

Annovis Bio (ANVS) Stock Surges 38% in a Month: Here's Why

Business Wire

2 years ago

CI&T Recognized in the 2023 Gartner® Magic Quadrant™ for Custom Software Development Services, Worldwide Report

7 Under-$10 Names to Put in Your Christmas Stocking

InvestorPlace

2 years ago

7 Under-$10 Names to Put in Your Christmas Stocking

Your Local Newspaper Might Not Have a Single Reporter

The Wall Street Journal

2 years ago

Your Local Newspaper Might Not Have a Single Reporter

Shareholders in Lee Enterprises (NASDAQ:LEE) are in the red if they invested five years ago

Simply Wall St.

2 years ago

Shareholders in Lee Enterprises (NASDAQ:LEE) are in the red if they invested five years ago

Valens Semiconductor's New USB3.2 Extension Solution Named as CES 2024 Innovation Awards Honoree

PR Newswire

2 years ago

Valens Semiconductor's New USB3.2 Extension Solution Named as CES 2024 Innovation Awards Honoree

Purple Biotech Reports Third Quarter 2023 Financial Results

GlobeNewswire

2 years ago

Purple Biotech Reports Third Quarter 2023 Financial Results

Decisionpoint Systems, Inc. (AMEX:DPSI) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Decisionpoint Systems, Inc. (AMEX:DPSI) Q3 2023 Earnings Call Transcript

Reuters

2 years ago

FOCUS-Researchers return to Alzheimer's vaccines, buoyed by recent drug success

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Ci&T Inc Earnings Call

Quantum Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing

PR Newswire

2 years ago

Quantum Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing

HIGHLIGHTS: Join CEO of Live Ventures in Fireside Chat

IPO-Edge.com

2 years ago

HIGHLIGHTS: Join CEO of Live Ventures in Fireside Chat

CI&T Inc. (CINT) Q3 Earnings Lag Estimates

Zacks

2 years ago

CI&T Inc. (CINT) Q3 Earnings Lag Estimates

Sonim Technologies Third Quarter 2023 Earnings: EPS: US$0.013 (vs US$0.045 loss in 3Q 2022)

Simply Wall St.

2 years ago

Sonim Technologies Third Quarter 2023 Earnings: EPS: US$0.013 (vs US$0.045 loss in 3Q 2022)

Sonim Appoints Mike Mulica as Board Chair

Newsfile

2 years ago

Sonim Appoints Mike Mulica as Board Chair

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

ACCESSWIRE

2 years ago

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

Vaxxinity to Present at Upcoming November Medical and Investor Conferences

GlobeNewswire

2 years ago

Vaxxinity to Present at Upcoming November Medical and Investor Conferences

The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Announce Appointment of New Chairman of the Board

Business Wire

2 years ago

The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Announce Appointment of New Chairman of the Board

Quantum Files Form 12b-25 Notification of Late filing

PR Newswire

2 years ago

Quantum Files Form 12b-25 Notification of Late filing

PLBY Group, Inc. (NASDAQ:PLBY) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

PLBY Group, Inc. (NASDAQ:PLBY) Q3 2023 Earnings Call Transcript

Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2023 Earnings Call Transcript

Virgin Galactic stock soars as company announces job cuts, spacecraft shift

Yahoo Finance

2 years ago

Virgin Galactic stock soars as company announces job cuts, spacecraft shift

Share on Social Networks: